A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether BIIB022, Paclitaxel and Carboplatin are
effective in the treatment of Treatment-Naive, Stage IIIB/IV Non-Small Cell Lung Cancer.